Chromatographic Lipase Separation for Stable Protein Formulations
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing bioprocessing methods struggle to efficiently separate host cell proteins (HCPs) like lipases from production proteins such as monoclonal antibodies, which are critical for ensuring biopharmaceutical safety and efficacy, and also fail to maintain polysorbate-80 (PS-80) stability in drug formulations.
Innovation Solution
The method involves optimizing chromatographic processes by controlling the separation factor (α) and partition coefficient (Kp) to effectively separate HCPs from production proteins, using specific resin types and operating conditions, including pH and salt concentrations, to achieve efficient separation and improve PS-80 stability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional chromatographic methods are used to separate HCPs from production proteins, then some separation is achieved, but the separation efficiency is insufficient and HCP levels remain too high
Solution Approach 1:
The patent applies parameter changes by systematically optimizing chromatographic conditions including pH (ranging from 4.0 to 8.0), ionic strength (0.1M to 1.0M salt concentration), and temperature (4°C to 37°C) to maximize the separation factor α between HCPs and production proteins. This allows achieving log α > 0.5, thereby resolving the insufficient separation efficiency of conventional methods
Solution Approach 2:
The patent employs dynamic optimization of chromatographic parameters during the separation process. The method involves adjusting pH gradients, salt concentration gradients, and flow rates dynamically to enhance separation efficiency at different stages of chromatography, enabling effective removal of HCPs while maintaining production protein activity
2Manufacturing precision
If chromatographic processes are optimized for HCP separation, then separation factor increases, but process complexity increases
Solution Approach 1:
The patent achieves high separation factors (log α > 0.5) by changing physical-chemical parameters such as pH, ionic strength, and temperature rather than by adding complex equipment. This approach increases separation efficiency while maintaining relatively simple chromatographic system architecture
Solution Approach 2:
The patent develops universal chromatographic conditions that can separate different types of HCPs (lipases, proteases, nucleases) from various production proteins using the same basic chromatographic platform. This multi-functionality reduces the need for multiple specialized processes, thereby limiting device complexity
3Ease of manufacture
If HCPs are not removed from production proteins, then process is simpler, but PS-80 stability in formulation deteriorates
Solution Approach 1:
The patent applies preliminary anti-action by removing HCPs (particularly lipases) before final formulation to prevent their harmful effect on PS-80 stability. The chromatographic separation is performed as a preliminary step to eliminate enzymes that would otherwise degrade polysorbate-80 in the final drug product, thereby maintaining formulation stability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach achieves high-purity production proteins with reduced HCP levels and enhanced PS-80 stability, meeting regulatory standards and ensuring the safety and efficacy of biopharmaceuticals.
Implementation Method 1
passing a load fluid comprising the lipase and the production protein through a chromatographic resin under a loading operating condition
Implementation Method 2
separation factor (α) is the ratio of the partition coefficient (Kp) for the lipase to the Kp for the production protein
Data Source
Figure 1A~1C
Figure 1D~1F
Figure 2A~2B
AI summary
Provided herein are methods of separating host cell lipases from a production protein in chromatographic processes and methods of improving polysorbate-80 stability in a production protein formulation by separating host cell lipases from the production protein using chromatographic processes. Also provided are pharmaceutical compositions comprising less than 1 ppm of a host cell lipase.